Veeva Systems Inc.
HealthcareNYSE:VEEV · New York Stock Exchange
-$2.58 today
Vol 1.90M · Avg 3.36M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$3.3B of revenue converted into $941.7M of net income for the selected period. Gross margin is 75.0% and net margin is 28.3%, showing how much revenue survives after costs and taxes. EPS is $5.61, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B +16.3% | $2.7B +16.2% | $2.4B +9.7% | $2.2B +16.4% | $1.9B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $782.0M +11.8% | $699.6M +3.3% | $677.3M +11.1% | $609.4M +21.0% | $503.7M | $344.8M | $725.6M | $804.0M |
| Gross Profit | $2.4B +17.9% | $2.0B +21.4% | $1.7B +9.1% | $1.5B +14.7% | $1.3B | $10.3B | $8.9B | $7.6B |
| Gross Margin | 75.5% +1.0pp | 74.5% +3.2pp | 71.3% -0.4pp | 71.7% -1.1pp | 72.8% | 45.5% | 9.8% | 28.9% |
| Research & Development | $767.4M +10.7% | $693.1M +10.2% | $629.0M +20.9% | $520.3M +36.2% | $382.0M | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | $729.5M +10.1% | $662.5M +5.5% | $628.0M +10.9% | $566.3M +23.2% | $459.6M | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $1.5B +10.4% | $1.4B +7.8% | $1.3B +15.7% | $1.1B +29.1% | $841.6M | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $0 -100.0% | $39.4M +20.7% | $32.6M +12.0% | $29.1M +6.1% | $27.4M | $1.2B | $374.2M | $1.2B |
| EBITDA | $1.2B +24.6% | $958.8M +54.5% | $620.7M +15.3% | $538.2M -0.3% | $539.8M | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 37.4% +2.5pp | 34.9% +8.6pp | 26.3% +1.3pp | 25.0% -4.2pp | 29.2% | 10.0% | 5.6% | 46.3% |
| Operating Income | $916.4M +32.5% | $691.4M +61.0% | $429.3M -6.5% | $459.1M -9.2% | $505.5M | $10.6B | $12.3B | $14.0B |
| Operating Margin | 28.7% +3.5pp | 25.2% +7.0pp | 18.2% -3.1pp | 21.3% -6.0pp | 27.3% | 18.7% | 16.6% | 24.1% |
| Interest Income | $0 -100.0% | $208.0M +55.5% | $133.7M +191.6% | $45.9M +211.3% | $14.7M | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | $278.1M +22.0% | $227.9M +43.6% | $158.7M +217.3% | $50.0M +633.7% | $6.8M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $1.2B +29.9% | $919.4M +56.4% | $588.0M +15.5% | $509.1M -0.6% | $512.3M | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 37.4% +3.9pp | 33.5% +8.6pp | 24.9% +1.3pp | 23.6% -4.1pp | 27.7% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $285.6M +39.2% | $205.2M +229.3% | $62.3M +191.3% | $21.4M -74.8% | $84.9M | $666.8M | $1.3B | -$1.6B |
| Net Income | $908.9M +27.3% | $714.1M +35.8% | $525.7M +7.8% | $487.7M +14.1% | $427.4M | $5.0B | $4.9B | $4.8B |
| Net Margin | 28.4% +2.4pp | 26.0% +3.8pp | 22.2% -0.4pp | 22.6% -0.5pp | 23.1% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $6 +25.9% | $4 +34.9% | $3 +4.1% | $3 +12.5% | $3 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $5 +25.9% | $4 +34.2% | $3 +7.3% | $3 +14.1% | $3 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $163.7M +1.1% | $161.9M +0.8% | $160.5M +3.3% | $155.4M +1.4% | $153.3M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $167.0M +1.1% | $165.2M +1.1% | $163.5M +0.6% | $162.4M +0.1% | $162.3M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
argenx SE
NASDAQ:ARGX
$55.58B
Becton, Dickinson and Company
NYSE:BDX
$52.91B
Cardinal Health, Inc.
NYSE:CAH
$52.52B
Edwards Lifesciences Corporation
NYSE:EW
$48.93B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.15B
Haleon plc
NYSE:HLN
$40.37B
Agilent Technologies, Inc.
NYSE:A
$36.57B
IQVIA Holdings Inc.
NYSE:IQV
$29.93B
GE HealthCare Technologies Inc.
NASDAQ:GEHC
$29.57B
Bruker Corporation
NASDAQ:BRKR
$8.17B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does VEEV generate?
Veeva Systems Inc. (VEEV) reported $3.20B of revenue in fiscal 2026.
Is VEEV profitable?
Veeva Systems Inc. (VEEV) reported $908.91M of net income, with a net margin of 28.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.